JW Holland Wellness & Aesthetics
- IV Therapy
- IV Hydration
- Peptide Therapy
- Hormone Replacement Therapy (HRT)
Tulsa, OK
Tulsa's IV therapy market is mid-size but unusually developed for a city of its scale, thanks to a strong functional and integrative medicine scene and a local aesthetic-medicine cluster. Clinics concentrate along Cherry Street, in Brookside, near Utica Square, and in South Tulsa and Jenks. Saint Francis Health System, Ascension St. John, and Hillcrest anchor the conventional clinical ecosystem supplying many medical directors. Oklahoma is a restricted-practice state for nurse practitioners, requiring physician supervision for prescribing, so Tulsa IV clinics run under physician-director models with RNs administering through standing orders. Tulsa's oil and gas corporate economy drives executive wellness demand, the runner community (Route 66 Marathon) supports athletic recovery, and hot Oklahoma summers sustain hydration volume. Aesthetic and longevity clinics in South Tulsa layer IV therapy onto broader anti-aging programs.
Regulatory context
FDA regulates the compounded ingredients used in IV therapy and the facilities that prepare them. Patient-specific compounded IVs fall under FDCA Section 503A, while bulk preparations for office use fall under Section 503B (outsourcing facilities). USP Chapter 797 governs sterile compounding standards. FDA has issued warnings about injectable glutathione marketed for skin lightening (2017) and has not approved NAD IV for any specific indication. Vitamin and mineral IV mixtures such as the Myers cocktail are compounded preparations and are not FDA-approved drug products.
The Oklahoma medical and nursing boards have addressed unlicensed practice in medical spa and IV lounge settings. Common enforcement themes include IV therapy administered without a valid physician order, stale or missing standing orders, absence of a designated medical director, and unlicensed personnel performing venipuncture. Boards have reiterated that a prescribing physician or APRN must establish a bona fide patient relationship before any IV protocol is initiated, and that standing orders must be specific, dated, and periodically reviewed.